The U.S. Preventive Services Task Force today recommended clinicians offer pre-exposure prophylaxis (PrEP), a pill that helps prevent the spread of HIV, to high-risk patients. High-risk behaviors include having a sex partner with HIV, having sex without a condom with a partner at high risk for HIV and sharing needles or other equipment while injecting drugs, the panel said. PrEP is highly effective at preventing HIV if taken daily, but people who take the pill should continue to use condoms and practice other behaviors to reduce their risk of other sexually transmitted infections, the task force said. It also continued to recommend that clinicians screen for HIV in pregnant women, everyone aged 15 to 65, and others at increased risk for HIV. The panel assigned an “A" grade to the recommendations, meaning all copays and deductibles would be waived under the Affordable Care Act.

Headline
The American Cancer Society released updated colorectal cancer screening guidelines May 27 that include the addition of a blood-based screening test to be…
Headline
The Centers for Disease Control and Prevention will host a webinar for clinicians May 28 at 2 p.m. ET on the ongoing Ebola outbreak in the Democratic…
Headline
The Centers for Disease Control and Prevention released a Health Alert Network Health Advisory May 8 notifying clinicians and health departments of the…
Headline
The Centers for Medicare & Medicaid Services April 13 announced that more than 150 organizations have been accepted to participate in the launch of its…
Headline
The AHA and dozens of other organizations April 14 sent a letter of support to Reps. Suzan DelBene, D-Wash., and Mike Kelly, R-Pa., for their introduction…
Headline
The Department of Health and Human Services and Centers for Medicare & Medicaid Services announced members of the Healthcare Advisory Committee March 26.…